Clinical Trials Directory

Trials / Unknown

UnknownNCT06009445

Renal Resistive Index as a Predictor of Acute Kidney Injury and Evaluation of Fluid Administration in Sepsis

Renal Resistive Index by Renal Doppler Ultrasound as a Predictor of Acute Kidney Injury and Evaluation of Fluid Administration in Sepsis Patients: Cohort Study

Status
Unknown
Phase
Study type
Observational
Enrollment
45 (estimated)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

We aim from this study to investigate the role of renal resistance index (RRI) in evaluation of Acute kidney injury development and fluid administration in sepsis patients considering the change in RRI values over 7 days from admission as a predictor of AKI development

Detailed description

Acute kidney injury (AKI) is one of the most common problems in critically ill patients in the clinic. AKI can be caused by various factors, such as hypovolemia, shock, major surgery, trauma, and heart failure, of which sepsis is the most common

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTRenal resistive indexThe calculation formula for Renal resistive index (RRI) as follows : (systolic peak flow velocity \_ diastolic minimum flow velocity )/systolic peak flow velocity . will be measured with ultrasound-Doppler using an abdominal curvilinear probe ultrasonography by two independent, trained sonographers (who will not be involved in patient care. After visualizing the kidney in ultrasound mode and checking for renal abnormalities, an arcuate or interlobar artery will be localized and three successive doppler measurements at different positions in the kidney (high, middle and low) will be performed, 3 times in each kidney. So a total number of 9 RRI values will be obtained in each kidney. The median value of each section will be used and the 3 median values of each kidney will be averaged.

Timeline

Start date
2023-07-01
Primary completion
2024-07-01
Completion
2024-07-01
First posted
2023-08-24
Last updated
2023-08-24

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06009445. Inclusion in this directory is not an endorsement.